Employee Stories
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company
Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.
All Patients Enrolled for the Phase III Clinical Trial of Luye Pharma’s Ruoxinlin® for Treating Generalized Anxiety Disorder
Shanghai, August 18, 2025 –- Luye Pharma Group announced that all patients have been enrolled for a Phase 3 clinical trial of its Ruoxinlin® (Toludesvenlafaxine Hydrochloride Sustained-Release Tablets) designated as a Class 1 ...
August 18,2025
First Subject Enrolled in Phase 1 Clinical Trial for Luye Pharma’s Investigational Antidepressant Targeting NET/DAT/GABAAR
Shanghai, August 3, 2025 -- Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China’s Class 1 pathway for innovative drugs. LY03021 is an ...
August 03,2025
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company